This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kurume University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Yushiro Yamashita: Innovator in Rett Syndrome Treatment
Introduction
Yushiro Yamashita is a notable inventor based in Kurume, Japan. He has made significant contributions to the field of medical research, particularly in the treatment of Rett Syndrome (RTT). His innovative approach involves the use of ghrelin, a hormone that plays a role in various physiological processes.
Latest Patents
Yamashita holds a patent for a method of treating Rett Syndrome with ghrelin. This patent outlines a method that comprises administering ghrelin to a subject in need thereof. His work in this area has the potential to improve the quality of life for individuals affected by this condition.
Career Highlights
Yamashita is affiliated with Kurume University, where he conducts research and develops new treatment methodologies. His academic background and dedication to medical innovation have positioned him as a key figure in his field.
Collaborations
Yamashita has collaborated with notable colleagues, including Munetsugu Hara and Toyojiro Matsuishi. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments.
Conclusion
Yushiro Yamashita's contributions to the treatment of Rett Syndrome through his innovative use of ghrelin highlight his commitment to advancing medical science. His work continues to inspire future research in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile